VIS was established in August 2021. As of January 2022, VIS is registered with AIFA as a CRO meeting the requirements of the Ministerial Decree of 15 November 2011 for the following activities: authorization process, Project Management, Medical Writing, Secretariat of Pharmacovigilance, Quality Assurance consulting services, training services inherent to clinical trials, monitoring. The services that VIS can offer are Start-up, Project Management, Site Management, Quality Assurance of CROs and/or Phase I centers, Management of essential documents, remote and on-site Monitoring, Training. VIS offers customised consulting, targeted training, simple and effective solutions for the development and management of clinical trials with drugs and medical devices. Although VIS is a very young company, it has highly qualified staff with more than 15 years of experience in clinical drug research. Since 2022, VIS has also become a consultant for the design and execution of clinical investigations with medical devices (according to ISO 14155:202). Our customers are clinicians, scientific societies, public and private companies in the healthcare sector, national and international CROs. Our strength is therefore our flexibility and the large network we have created over the years. VIS is more than a CRO: small enough to maintain a balanced relationship between work and quality of life, but organised enough to meet the needs of our customers.
